Dosage device
Latest Novartis AG Patents:
- 5-hydroxy-7-oxabicyclo[2.2.1]heptane-2-carboxamide derivatives for inducing chondrogenesis for treating joint damage
- Solid support
- Antibody molecules to LAG-3 and uses thereof
- Crystalline forms of N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide
- Crystalline forms OF N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide
Description
FIG. 1 is a front elevational view of a dosage device showing our new design;
FIG. 2 is a rear elevational view thereof;
FIG. 3 is a right side elevational view thereof;
FIG. 4 is a left side elevational view thereof;
FIG. 5 is a front elevational view of a second embodiment of a dosage device showing our new design;
FIG. 6 is a left side elevational view thereof;
FIG. 7 is a rear elevational view thereof; and,
FIG. 8 is a right side elevational view thereof.
Claims
The ornamental design for a dosage device, as shown and described.
Referenced Cited
Patent History
Patent number: D474841
Type: Grant
Filed: Jan 23, 2002
Date of Patent: May 20, 2003
Assignee: Novartis AG (Basel)
Inventors: Phil T. Price (Oxford), Stephanie Bley (Basel), Bernard Sams (London)
Primary Examiner: Ian Simmons
Attorney, Agent or Law Firm: John D. Thallemer
Application Number: 29/154,433
Type: Grant
Filed: Jan 23, 2002
Date of Patent: May 20, 2003
Assignee: Novartis AG (Basel)
Inventors: Phil T. Price (Oxford), Stephanie Bley (Basel), Bernard Sams (London)
Primary Examiner: Ian Simmons
Attorney, Agent or Law Firm: John D. Thallemer
Application Number: 29/154,433
Classifications
Current U.S. Class:
Hand Manipulated Tool Or Instrument (23) (D24/133);
Pipette Or Burette (D24/222)
International Classification: 2402;
International Classification: 2402;